RT @sciRPatel: Fun collaboration with Dr. Wang and Dr. Blaser on studying immunologic and molecular signatures during AML treatment - my fi…
1,160 followers
2,952 followers
#ICYMI: Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis by Charalambos Andreadis, Victoria E. Wang and colleagues @UCSFDOM. https://t.co/RcG9Ks7oWO https://t.
11,798 followers
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis https://t.co/EPXEUDFIvC
0 followers
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes… https://t.co/GKxpNCSFIQ